Akorn Gets Del. Ch. 11 Disclosure OK As Plan Fight Looms
Bankrupt pharmaceutical company Akorn Inc. secured Delaware court approval Wednesday for its Chapter 11 disclosure, while also receiving a preview of coming dissents over its more than $1 billion case and...To view the full article, register now.
Already a subscriber? Click here to view full article